4//SEC Filing
LEE JENNIFER LING 4
Accession 0001127602-20-009068
CIK 0001682852other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:50 PM ET
Size
7.5 KB
Accession
0001127602-20-009068
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
LEE JENNIFER LING
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-28+16,112→ 16,112 totalExercise: $25.93From: 2021-02-28Exp: 2030-02-28→ Common Stock (16,112 underlying) - Award
Restricted Stock Units
2020-02-28+8,677→ 8,677 totalExercise: $0.00From: 2021-02-28→ Common Stock (8,677 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001675118
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:50 PM ET
- Size
- 7.5 KB